The coronavirus count in India crossed the 90 lakh mark on Friday with 45,882 new infections reported in the past 24 hours, the Union Health and Family Ministry said on Friday.
The total number of cases in the country now stands at 90 04 366 including 4,434,794 active cases and 84 28,409 recoveries. With 584 new deaths, the tally rose to 1,32,162.
This is the 13th day in a row India has reported less than 50,000 cases per day. The last time new daily cases crossed the 50,000-person threshold was on November 7.
Meanwhile, Prime Minister Narendra Modi on Friday held a virtual meeting with senior officials, including those from the NITI Aayog Center think tank, on India’s strategy to develop a COVID-19 vaccine and make it accessible. to the masses.
“Held a meeting to review India’s immunization strategy and the way forward. Important issues related to vaccine development advancement, regulatory approvals and procurement were discussed,” PM tweeted Modi.
Here are the live updates on the coronavirus cases:
The Trump administration is ready with a plan to distribute the COVID-19 vaccine across the country as soon as the U.S. Food and Drug Administration gives them the necessary emergency use clearance, the White House said on Friday.
No less than 40 million doses of this vaccine will be available by the end of the year, he said.
“As for the vaccine, we think there will be 40 million doses available by the end of the year. Again, this is extraordinary. It is the fastest vaccine in the world. story, multiplied by five, “White House spokeswoman Kayleigh McEnany told reporters at a press conference here.
“It was only possible thanks to this president, who said at the same time, ‘I’m looking for a vaccine; I’m going to do something new. I’m going to make it.’ “So many American lives will be saved thanks to President Trump and the great work of Operation Warp Speed,” she said.
External advisers from the Food and Drug Administration will meet on December 10 to discuss whether to authorize the COVID-19 vaccine developed by Pfizer Inc and its German partner BioNTech for emergency use, the agency said on Friday. .
The move comes after Pfizer requested authorization for its COVID-19 vaccine earlier today, the first such application in a major step towards protection against the novel coronavirus.
“While we cannot predict how long the FDA review will take, the FDA will review the application as quickly as possible,” FDA Commissioner Stephen Hahn said in a statement.
The meeting of the Advisory Committee on Vaccines and Related Biologics will discuss the safety and efficacy of the candidate vaccine.
The eldest son of US President Donald Trump, Donald Trump Jr, has tested positive for Covid-19 and has been quarantined without symptoms, a spokesperson said on Friday.
“Don tested positive earlier this week and has been in quarantine in his cabin since the result,” his spokesperson said.